Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 3Prostatic Neoplasms 1Depression 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 90Blood Specimen Collection 41Cyclophosphamide 37Bevacizumab 36Nivolumab 34Standard of Care 32Carboplatin 32Surveys and Questionnaires 29Paclitaxel 27atezolizumab 25Exercise 25Pemetrexed 24Cisplatin 24Gemcitabine 23Fluorouracil 22Radiotherapy 20Leucovorin 20Dexamethasone 20Oxaliplatin 18Docetaxel 18Rituximab 16Irinotecan 16Cetuximab 16Drug Therapy 15Doxorubicin 15dostarlimab 14Biopsy 14130-nm albumin-bound paclitaxel 14fludarabine 13Prednisone 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Stress Mindset Measure × 1 year × Clear all
NCT06811454 2026-01-23

Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)

Case Comprehensive Cancer Center

Phase NA Not yet recruiting
76 enrolled
BreastGastrointestinalGenitourinary

Breast Neoplasms, Depression, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06705218 2026-01-07

EMBRACE

Stanford University

Phase NA Recruiting
440 enrolled
Tumor-Agnostic

Neoplasms

NCT04020029 2025-12-19

Leveraging Mindsets to Improve Health and Wellbeing in Patients With Cancer

Stanford University

Phase NA Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡